SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $399,419 | +70.2% | 3,295 | +60.8% | 0.03% | +80.0% |
| Q2 2023 | $234,651 | -48.8% | 2,049 | -38.4% | 0.02% | -51.6% |
| Q1 2023 | $458,698 | +6.4% | 3,328 | 0.0% | 0.03% | -6.1% |
| Q4 2022 | $431,242 | +42.8% | 3,328 | +21.7% | 0.03% | +32.0% |
| Q3 2022 | $302,000 | -50.9% | 2,734 | -24.3% | 0.02% | -67.1% |
| Q4 2020 | $615,000 | +0.5% | 3,611 | -17.2% | 0.08% | -12.6% |
| Q3 2020 | $612,000 | +7.4% | 4,360 | +22.5% | 0.09% | -2.2% |
| Q2 2020 | $570,000 | +63.8% | 3,560 | 0.0% | 0.09% | +29.0% |
| Q1 2020 | $348,000 | -17.7% | 3,560 | +8.5% | 0.07% | +1.5% |
| Q4 2019 | $423,000 | +71.3% | 3,280 | 0.0% | 0.07% | +58.1% |
| Q3 2019 | $247,000 | -41.7% | 3,280 | +17.6% | 0.04% | -43.4% |
| Q2 2019 | $424,000 | +27.7% | 2,790 | 0.0% | 0.08% | +8.6% |
| Q1 2019 | $332,000 | +89.7% | 2,790 | +73.3% | 0.07% | +66.7% |
| Q4 2018 | $175,000 | +80.4% | 1,610 | +168.3% | 0.04% | +100.0% |
| Q3 2018 | $97,000 | – | 600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |